Xtacy Therapeutics Corp.

  • Market Cap: N/A
  • Industry: Capital Markets
  • ISIN: CA98423G1072
CAD
0.05
0.04 (290.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Xtacy Therapeutics Corp. stock-summary
stock-summary
Xtacy Therapeutics Corp.
Capital Markets
Redfund Capital Corp is a Canada-based merchant bank. The Company is focused on medical cannabis and hemp in both Canada and the United States. It intends to provide debt and equity funding in the mid-to-late stages of a target company’s development or in technologies that are developed and validated by revenues. It also offers advisory services to companies.
Company Coordinates stock-summary
Company Details
1100 - 1111 Melville St , VANCOUVER BC : V6E 3V6
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

CAD 0 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

43.38%

stock-summary
Price to Book

-0.23